Gavis Pharmaceuticals Llc


'Gavis Pharmaceuticals Llc' - 6 News Result(s)

  • Lupin Gets USFDA Nod For Potassium Deficiency Treatment Drug

    Lupin Gets USFDA Nod For Potassium Deficiency Treatment Drug

    Pharma major Lupin's US arm Gavis Pharmaceuticals LLC has received final approval from the USFDA for its generic version of Upsher-Smith Labs' Klor-Con tablets used for treating potassium deficiency in blood.

  • Lupin Gets USFDA Nod For Fungal Infection Drug

    Lupin Gets USFDA Nod For Fungal Infection Drug

    Lupin has received final approval from the US health regulator to market generic Voriconazole tablets as well as oral suspension for treatment of fungal infections in the American market.

  • Lupin Gets US Drug Regulator's Final Nod For Fungal Treatment Drug

    Lupin Gets US Drug Regulator's Final Nod For Fungal Treatment Drug

    According to IMS MAT March 2016 sales data, Vfend tablets, 50 mg and 200 mg, had sales of $92.8 million while Vfend Oral Suspension, 40 mg/mL, had US sales of $15.9 million.

  • Lupin Completes Acquisition of GAVIS Pharma

    Lupin Completes Acquisition of GAVIS Pharma

    Drug major Lupin on Wednesday said it has completed the acquisition of privately-held, US-based GAVIS Pharmaceuticals LLC and Novel Laboratories (GAVIS).

  • Lupin, Gavis to Sell 2 Drugs for Deal Approval

    Lupin, Gavis to Sell 2 Drugs for Deal Approval

    Homegrown drug major Lupin and Gavis Pharmaceuticals LLC, which the Indian firm announced to acquire in an $850-million deal last year, have agreed to divest two generic drugs as part of the US Federal Trade Commission's (FTC) requirement to complete the transaction.

  • Lupin Looks to Revive US Growth With $880-Million GAVIS Deal

    Lupin Looks to Revive US Growth With $880-Million GAVIS Deal

    Lupin Ltd, India's third-largest drug maker by sales, is buying US peer GAVIS Pharmaceuticals LLC for $880 million (Rs 5,588 crore at $1 = Rs 63.5) in its largest ever acquisition, seeking to revive its flagging growth in the United States, its largest market.

'Gavis Pharmaceuticals Llc' - 6 News Result(s)

  • Lupin Gets USFDA Nod For Potassium Deficiency Treatment Drug

    Lupin Gets USFDA Nod For Potassium Deficiency Treatment Drug

    Pharma major Lupin's US arm Gavis Pharmaceuticals LLC has received final approval from the USFDA for its generic version of Upsher-Smith Labs' Klor-Con tablets used for treating potassium deficiency in blood.

  • Lupin Gets USFDA Nod For Fungal Infection Drug

    Lupin Gets USFDA Nod For Fungal Infection Drug

    Lupin has received final approval from the US health regulator to market generic Voriconazole tablets as well as oral suspension for treatment of fungal infections in the American market.

  • Lupin Gets US Drug Regulator's Final Nod For Fungal Treatment Drug

    Lupin Gets US Drug Regulator's Final Nod For Fungal Treatment Drug

    According to IMS MAT March 2016 sales data, Vfend tablets, 50 mg and 200 mg, had sales of $92.8 million while Vfend Oral Suspension, 40 mg/mL, had US sales of $15.9 million.

  • Lupin Completes Acquisition of GAVIS Pharma

    Lupin Completes Acquisition of GAVIS Pharma

    Drug major Lupin on Wednesday said it has completed the acquisition of privately-held, US-based GAVIS Pharmaceuticals LLC and Novel Laboratories (GAVIS).

  • Lupin, Gavis to Sell 2 Drugs for Deal Approval

    Lupin, Gavis to Sell 2 Drugs for Deal Approval

    Homegrown drug major Lupin and Gavis Pharmaceuticals LLC, which the Indian firm announced to acquire in an $850-million deal last year, have agreed to divest two generic drugs as part of the US Federal Trade Commission's (FTC) requirement to complete the transaction.

  • Lupin Looks to Revive US Growth With $880-Million GAVIS Deal

    Lupin Looks to Revive US Growth With $880-Million GAVIS Deal

    Lupin Ltd, India's third-largest drug maker by sales, is buying US peer GAVIS Pharmaceuticals LLC for $880 million (Rs 5,588 crore at $1 = Rs 63.5) in its largest ever acquisition, seeking to revive its flagging growth in the United States, its largest market.

Your search did not match any documents
A few suggestions
  • Make sure all words are spelled correctly
  • Try different keywords
  • Try more general keywords
Check the NDTV Archives:https://archives.ndtv.com

................................ Advertisement ................................

................................ Advertisement ................................

Listen to the latest songs, only on JioSaavn.com